Bioventix (BVXP) Competitors GBX 2,478 +28.00 (+1.14%) As of 09/23/2025 11:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BVXP vs. SLN, HZD, PRTC, VRP, AVCT, FARN, ARIX, CIR, 4BB, and TILSShould you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include Silence Therapeutics (SLN), Horizon Discovery Group plc (HZD.L) (HZD), PureTech Health (PRTC), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), 4basebio (4BB), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry. Bioventix vs. Its Competitors Silence Therapeutics Horizon Discovery Group plc (HZD.L) PureTech Health Verona Pharma plc (VRP.L) Avacta Group Faron Pharmaceuticals Oy Arix Bioscience Circassia Group 4basebio Tiziana Life Sciences Silence Therapeutics (LON:SLN) and Bioventix (LON:BVXP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Which has stronger earnings and valuation, SLN or BVXP? Bioventix has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/ABioventix£13.66M9.48£8.12M£1.481,672.97 Does the media refer more to SLN or BVXP? In the previous week, Bioventix had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for Bioventix and 0 mentions for Silence Therapeutics. Silence Therapeutics' average media sentiment score of 0.00 equaled Bioventix'saverage media sentiment score. Company Overall Sentiment Silence Therapeutics Neutral Bioventix Neutral Is SLN or BVXP more profitable? Bioventix has a net margin of 59.51% compared to Silence Therapeutics' net margin of 0.00%. Bioventix's return on equity of 69.09% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A Bioventix 59.51%69.09%54.07% Do insiders and institutionals believe in SLN or BVXP? 32.4% of Bioventix shares are held by institutional investors. 6.1% of Bioventix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryBioventix beats Silence Therapeutics on 9 of the 9 factors compared between the two stocks. Get Bioventix News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BVXP vs. The Competition Export to ExcelMetricBioventixBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£129.48M£231.57M£5.76B£2.57BDividend Yield6.45%3.78%5.53%5.33%P/E Ratio1,672.9734.2576.435,405.27Price / Sales9.484,650.68473.3197,176.40Price / Cash30.8913.1937.4627.93Price / Book10.78132.4913.619.12Net Income£8.12M-£90.99M£3.29B£5.89B7 Day Performance0.47%-0.33%1.87%1.08%1 Month Performance-0.88%18.15%4.03%3.03%1 Year Performance-37.66%714.38%77.41%193.30% Bioventix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BVXPBioventixN/AGBX 2,478+1.1%N/A-37.9%£129.48M£13.66M1,672.9712SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416PRTCPureTech Health2.2151 of 5 starsGBX 106.40-0.6%GBX 455+327.6%-11.7%£257.15M£6.17M625.88300High Trading VolumeVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 53.75+3.4%N/A-8.8%£215.95M£113K-350.39120FARNFaron Pharmaceuticals OyN/AGBX 185.10+0.1%N/A-8.4%£207.23MN/A-685.5634ARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down4BB4basebio1.2743 of 5 starsGBX 850+1.2%GBX 1,600+88.2%-46.4%£131.62M£933K-904.26101TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911 Related Companies and Tools Related Companies Silence Therapeutics Competitors Horizon Discovery Group plc (HZD.L) Competitors PureTech Health Competitors Verona Pharma plc (VRP.L) Competitors Avacta Group Competitors Faron Pharmaceuticals Oy Competitors Arix Bioscience Competitors Circassia Group Competitors 4basebio Competitors Tiziana Life Sciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BVXP) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BVXP Stock Alerts